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Staphylococcus aureus CcpA affects biofilm formation
Abstract
Biofilm formation in Staphylococcus aureus under in vitro growth conditions is generally promoted by
high concentrations of sugar and/or salts. The addition of glucose to routinely used complex growth
media triggered biofilm formation in S. aureus strain SA113. Deletion of ccpA, coding for the catabolite
control protein A (CcpA), which regulates gene expression in response to the carbon source, abolished
the capacity of SA113 to form a biofilm under static and flow conditions, while still allowing primary
attachment to polystyrene surfaces. This suggested that CcpA mainly affects biofilm accumulation and
intercellular aggregation. trans-Complementation of the mutant with the wild-type ccpA allele fully
restored the biofilm formation. The biofilm produced by SA113 was susceptible to sodium
metaperiodate, DNase I, and proteinase K treatment, indicating the presence of polysaccharide
intercellular adhesin (PIA), protein factors, and extracellular DNA (eDNA). The investigation of several
factors which were reported to influence biofilm formation in S. aureus (arlRS, mgrA, rbf, sarA, atl, ica,
citZ, citB, and cidABC) showed that CcpA up-regulated the transcription of cidA, which was recently
shown to contribute to eDNA production. Moreover, we showed that CcpA increased icaA expression
and PIA production, presumably over the down-regulation of the tricarboxylic acid cycle genes citB and
citZ.
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Biofilm formation in Staphylococcus aureus under in vitro growth conditions is generally promoted by high
concentrations of sugar and/or salts. The addition of glucose to routinely used complex growth media triggered
biofilm formation in S. aureus strain SA113. Deletion of ccpA, coding for the catabolite control protein A
(CcpA), which regulates gene expression in response to the carbon source, abolished the capacity of SA113 to
form a biofilm under static and flow conditions, while still allowing primary attachment to polystyrene
surfaces. This suggested that CcpA mainly affects biofilm accumulation and intercellular aggregation. trans-
Complementation of the mutant with the wild-type ccpA allele fully restored the biofilm formation. The biofilm
produced by SA113 was susceptible to sodium metaperiodate, DNase I, and proteinase K treatment, indicating
the presence of polysaccharide intercellular adhesin (PIA), protein factors, and extracellular DNA (eDNA).
The investigation of several factors which were reported to influence biofilm formation in S. aureus (arlRS,
mgrA, rbf, sarA, atl, ica, citZ, citB, and cidABC) showed that CcpA up-regulated the transcription of cidA, which
was recently shown to contribute to eDNA production. Moreover, we showed that CcpA increased icaA
expression and PIA production, presumably over the down-regulation of the tricarboxylic acid cycle genes citB
and citZ.
Staphylococcus epidermidis and Staphylococcus aureus are
the most frequent causes of foreign body-associated infections,
mainly due to their ability to form an adherent, multilayer
bacterial biofilm on all sorts of surfaces. Embedment in a
polymeric matrix protects bacteria from host defenses (3), and
the altered gene expression of the sessile form (43) renders
them refractory to antibiotic treatment.
Biofilm formation is a multistep process, characterized by
attachment of the cells to a surface by physicochemical inter-
actions, which is followed by growth-dependent intercellular
accumulation, glycocalyx formation, maturation of the biofilm,
and finally escape of the bacteria from the biofilm (22). Besides
the overall cell charge and hydrophobicity, which can affect
initial attachment to various surfaces, staphylococci possess an
impressive number of surface-associated adhesins (microbial
surface components recognizing adhesive matrix molecules, or
MSCRAMMS) to adhere to the host’s matrix proteins (20).
The genetic and molecular basis of biofilm formation in staph-
ylococci is multifaceted (reviewed in reference 39), and the
composition of the polymeric biofilm matrix is complex and
varies from strain to strain (9).
An important component of many S. epidermidis biofilms is
the polysaccharide intercellular adhesin, PIA, also termed
polymeric N-acetylglucosamine (PNAG), which is synthesized
by the icaADBC-encoded proteins (34, 35). PIA is also pro-
duced by S. aureus (13), and the ica operon appears to be
present in virtually all S. aureus strains (17, 29, 46). However,
the role and importance of PIA in different clinical settings are
not completely understood (46). Biofilm formation can also
occur in several PIA-independent ways (2): The teichoic acids,
surface-exposed charged polymers, which constitute an impor-
tant part of the S. aureus cell wall, function in primary adher-
ence (23, 57) and are a component of the biofilm matrix as well
(49). Proteinaceous factors also contribute significantly to pri-
mary attachment and/or promote biofilm formation. Among
them are the bifunctional autolysin Atl, which is involved in
cell separation (4, 24); possibly also the related cell wall-asso-
ciated proteins SasG and Pls (12); the biofilm-associated pro-
tein Bap, which is mainly found in bovine S. aureus lineages
(31); and the aggregation-associated protein Aap from S. epi-
dermidis, which, upon proteolytic processing, induces a PIA-
independent biofilm-positive phenotype (47). Functions in
biofilm formation were reported also for -hemolysin, a
secreted toxin, but required for cell-cell interactions and
biofilm formation (5), as well as for FmtA (16, 55), a peni-
cillin-binding-like protein that plays a role in methicillin
resistance (30). Besides proteins, extracellular DNA (eDNA)
seems to be a major structural component in staphylococcal
biofilms (26, 42, 44).
The regulation of biofilm formation is complex and is influ-
enced by various regulatory systems. The alternative stress
sigma factor B is important in biofilm formation in S. epider-
midis but plays a minor role in S. aureus (29, 56). The staph-
ylococcal accessory regulator SarA, which controls the synthe-
sis of certain virulence factors directly or via the agr system and
which itself is partly controlled by B, is essential for biofilm
formation in several S. aureus strains (1). Mutations of the
accessory gene regulator (agr) were found to affect biofilm
formation in some but not all S. aureus strains analyzed (40). A
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two-component system which positively controls biofilm for-
mation in S. aureus is WalK/WalR, also known as YycG/YycF
(15), which plays an important role in cell wall modeling
through activation of several genes involved in cell wall deg-
radation.
Several environmental factors have been reported to affect
biofilm formation (reviewed in references 22, 33, and 39).
Anaerobiosis stimulates ica transcription in S. aureus (14), and
growth of S. aureus during infection of a host results in higher
PIA production than under in vitro conditions (37). The rela-
tive amounts of extracellular PIA and teichoic acids depend on
growth conditions such as the choice of the medium or on
agitation (49). Especially the presence of sugars seems to play
an important role in the stimulation of this process (18, 29).
The impact of glucose in the induction of biofilm formation in
S. aureus is also reflected by the fact that most of the biofilm
adherence assays used in previous studies included high con-
centrations of either glucose or sucrose (1, 5, 13, 14, 19, 27, 32,
51, 54). Rbf, a member of the AraC/XylS family, was recently
suggested to be involved in the regulation of the multicellular
aggregation step of S. aureus biofilm formation in response to
glucose or salt (32).
We recently showed the impact of the catabolite control
protein A (CcpA) on carbon metabolism, up-regulation of
certain virulence determinants, and resistance to cell wall-di-
rected antibiotics (50). Since the activity of CcpA is activated in
the presence of glucose or sucrose (27), and since CcpA was
shown to affect biofilm formation in Bacillus subtilis and Strep-
tococcus mutans (7, 53, 58), we wondered about its role in
biofilm formation in S. aureus.
In this study, we deleted the ccpA gene in strain SA113, a
biofilm former known to produce PIA (13). We show that,
depending on the growth medium, SA113 was able to form a
strong biofilm and that the deletion of ccpA reduced its biofilm
formation capacity and PIA production.
MATERIALS AND METHODS
Bacterial strains and plasmids. The S. aureus strains, plasmids, and primers
used in this study are listed in Tables 1 and 2. All strains generated for this study
were confirmed by Southern blot analysis and pulsed-field gel electrophoresis of
total genome SmaI digests.
Biofilm assays. Biofilm formation under static conditions was monitored as
described in reference 32. Briefly, Trypticase soy broth (TSB), brain heart infu-
sion (BHI), or LB medium (Becton Dickinson), supplemented with different
amounts of glucose, was inoculated 1:200 with an overnight culture. Two hun-
dred microliters of this suspension was transferred to wells of 96-well Nunc Delta
tissue culture plates (Roskilde, Denmark) and incubated for 18 h at 37°C. After
incubation, the wells were rinsed with 200 l phosphate-buffered saline three
times, air dried, stained with 0.1% safranin for 30 s, and washed three times with
distilled water. The adhering dye was dissolved with 30% acetic acid, and the
absorption was measured at 530 nm in a microtiter dish reader (Powerwave XS;
BioTek). Analoguous experiments were carried out in Nunc 12-well plates using
1 ml of the corresponding suspensions or solutions for a better visual observa-
tion.
Biofilm formation under flow conditions was determined basically as described
by Beenken et al. (1) using TSB supplemented with 1% glucose, uncoated
three-channel flow cells (total volume, 160 l), and a flow rate of 0.5 ml min1
for 24 h.
Growth was monitored in 10-ml glass test tubes containing 2 ml of TSB
supplemented with 1% glucose and inoculated 1:200 with preculture. Cells were
grown for 18 h at 37°C with shaking (180 rpm).
Biofilm stability against protease, sodium metaperiodate, and DNase I treat-
ment. Biofilm stability assays were carried out in Nunc 12-well plates as described
by Toledo-Arana et al. (54), using the growth conditions described above and
TSB supplemented with 1% glucose. After 18 h, the medium was removed and
substituted with fresh medium supplemented with either 100 g/ml protease K or
10 mM of sodium metaperiodate and incubated for 2 h at 37°C. Medium without
supplement served as a negative control. To test the impact of DNase I, cells
were treated as described by Rice et al. (44). Briefly, cells were grown in TSB
supplemented with 1% glucose in the presence of 140 U/ml RNase-free DNase
I (Fluka, Switzerland) in test tubes or in Nunc plates for 18 h at 37°C. Addition
of DNase I had no effect on the growth rates of cells grown in liquid culture.
Growth on CRA. Congo red agar (CRA) screening was performed basically as
described by Knobloch et al. (29). Cells grown on blood plates were diluted to
McFarland standard of 0.5, stamped on plates made of TSB agar supplemented
with 1% glucose and 0.08% Congo red, and incubated for 18 h at 37°C. MICs of
Congo red were determined by broth microdilution modified according to CLSI
guidelines (11) in TSB supplemented with 1% glucose.
PIA determination. PIA production was monitored by analyzing the cell sur-
face extracts from cultures grown for 2 and 8 h in TSB supplemented with 1%
glucose. PIA was extracted as described by Cerca et al. (6). Detection was
performed using a rabbit polyclonal anti-PIA antibody (19) after blocking with
human immunoglobulin G.
TABLE 1. S. aureus strains and plasmids used in this study
Strain or
plasmid
Relevant genotype and
phenotypea
Source or
reference
Strains
MST04 RN4220 ccpA::tet(L); Tcr 50
SA113 ATCC 35556; PIA-dependent
biofilm producer
25
KS66 SA113 ccpA::tet(L); Tcr This study
KS66 compl KS66(pMST1); Kanr; Tcr This study
KS66 empty KS66(pAW17); Kanr Tcr This study
SA113 ica ATCC 35556 ica::tet; Tcr;
deletion of the icaADBC
operon
13
DSM 20231 Cowan serotype 3 52
KS153 DSM 20231 ccpA::tet(L); Tcr This study
KS153 compl KS153(pMST1); Kanr Tcr This study
Plasmids
pAW17 Escherichia coli-S. aureus
shuttle plasmid with ori
pAM1 and ori ColE1;
Kanr
48
pMST1 pAW17 with 1.7-kb PCR
fragment covering ccpA
and its proposed promoter;
Kanr
50
a Abbreviations: Tcr, tetracycline resistant; Kanr, kanamycin resistant.
TABLE 2. Primers used in this study
Primer Sequence (533) Source orreference
arlRSprobe TCGTATCACATACCCAACGC This study
arRSprobe GAGTATGATGGACAAGACGG This study
citBprobe CAGAGGTGTACCAGCCG This study
citBprobe GGTTGTCCAAGCATTCCAG This study
citZprobe CATCTGACAATGATGATACC This study
citZprobe GGAGTATGTTACAGATCACG This study
rbfprobe TGATTTACGTGACGAGCTCG This study
rbfprobe GCACTATTACTTAAATCTCG This study
atlprobe CCAAGGAACCATTGATAAGC This study
atlprobe TGATACTGCTAAACCTACGC This study
mgrAprobe TCTTGAGATAAAGAAGAAGC This study
mgrAprobe GAAGTACAATCTAACATACC This study
cidA1-F CCCATATGCACAAAGTCCA
ATTA
59
cidA1-R CCCTCGAGTTCATAAGCGTCT
ACACC
59
SasarAf AGGGAGGTTTTAAACATGGC 9a
SasarAr CTCGACTCAATAATGATTCG 9a
16S-F CGGAGTGCTTAATGCGTTAG This study
16S-R CAATGGGCGAAAGCCTG This study
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Primary adherence measurements. Primary adherence was measured by di-
luting cells in the stationary growth phase in TSB supplemented with 1% glucose
to obtain approximately 30 CFU/ml. Two milliliters of the appropriate dilutions
was added to Nunc Delta six-well-plates and incubated for 30 min at 37°C. In
parallel, cells were plated on blood plates to determine the original number of
cells applied to the microtiter plates. The six-well plates were rinsed gently three
times with 5 ml of sterile phosphate-buffered saline (pH 7.4) and covered with 3
ml of molten BHI agar (0.8%). Primary attachment was expressed as a percent-
age of CFU on the six-well-plates compared to the CFU on blood plates.
Quantification of icaA transcription. The icaA and gyrB transcripts were quan-
tified by LightCycler reverse transcription-PCR as described earlier (19) using
RNA samples obtained from cultures grown for 2 and 8 h in TSB supplemented
with 1% glucose at 37°C and 200 rpm.
Northern blot analyses. For Northern blot analyses, cells were grown in TSB
supplemented with 1% glucose and harvested after 2 h of growth, with both both
wild type and mutant having reached an optical density at 600 nm of approxi-
mately 0.4. Cells were centrifuged for 2 min at 12,000  g, and cell sediments
were snap-frozen in liquid nitrogen. RNA isolation and Northern blotting were
performed as described earlier (36). The primer pairs used to generate digoxi-
genin-labeled arlRS-, citB-, citZ-, rbf-, cidA-, mgrA-, atl-, and sarA-specific probes
by PCR labeling are shown in Table 2. All Northern blot analyses were per-
formed at least twice on independently isolated RNA samples. An internal 0.5-kb
fragment of the 16S rRNA genes (nucleotides 2232818 to 2233328 of GenBank
accession no. CP000046) was used to probe the 16S rRNA gene as a loading
control.
Triton X-100-induced autolysis assays. Autolysis assays were performed as
described by Fournier and Hooper (21). Bacteria were grown in TSB supple-
mented with 1% glucose for 2 h. Cells were pelleted by centrifugation and
resuspended in 50 mM Tris-HCl (pH 7.5)–0.1% Triton X-100 to obtain an A600
of approximately 1. The cells were then incubated at 30°C with shaking, and
changes in A600 and CFU were monitored. Results were normalized to CFU at
time zero (CFU0): i.e., % living cells at time t 	 (CFU at time t/CFU0)  100.
RESULTS AND DISCUSSION
Effect of glucose on biofilm formation in S. aureus SA113.
Biofilm formation of strain SA113 in different complex growth
media (TSB, BHI, and LB) was shown to be promoted by
adding increasing concentrations of glucose. Without glucose
supplementation (Fig. 1 A), no significant biofilm formation
(A530,
0.5) was observed irrespective of the fact that BHI and
TSB already contained substantial amounts of glucose, namely
11 and 14 mM, respectively. Interestingly, supplementation
with 0.2% glucose (10 mM) was sufficient to induce a visible
biofilm (A530, 1.5) in all three media tested, and a further
increase in glucose concentration up to 1% only slightly in-
creased biofilm formation. In contrast to the findings of Been-
ken et al. (1), who observed biofilm formation of SA113 in
polystyrene microtiter plates only in media that were supple-
mented with both sodium chloride (3%) and glucose and when
the wells of the microtiter plates were precoated with plasma
proteins, neither addition of 3% salt to the growth medium nor
precoating the microtiter plates with plasma proteins was es-
sential for, or increased biofilm formation of SA113 in our
experiments, suggesting that SA113 strains with altered adhe-
sion/biofilm-forming capacities may exist in different laborato-
ries.
Characteristics of the SA113 biofilm. The biofilm produced
by SA113 in TSB supplemented with 1% glucose was sodium
metaperiodate, proteinase K, and DNase I sensitive (Fig. 1B),
indicating the presence of PIA, proteinaceous factors, and
genomic eDNA. This is in line with previous observations (13)
and supports the assumption made by Rohde et al. (46) that
biofilm formation depends on protein factors in addition to
PIA. Moreover, it showed that DNA was also an important
structural component of the biofilm formed by this strain.
When strain SA113 was grown in glass tubes in TSB supple-
mented with 1% glucose, cells clumped together and sank to
the bottom of the tube, leading to a clearance of the medium
(Fig. 2). We analyzed this effect in the ica-negative strain
SA113 ica (13), which remained cloudy after growth in glass
tubes in TSB supplemented with 1% glucose (Fig. 2), indicat-
ing, that the clumping might be due to PIA production. Inter-
estingly, addition of DNase I (140 U/ml) to the growth medium
suppressed the clumping as well (data not shown), suggesting
that clumping requires the simultaneous presence of PIA and
eDNA.
Effect of CcpA on biofilm formation. Since glucose supple-
mentation promotes biofilm formation, we analyzed the role of
the catabolite control protein A (CcpA) in this process. We
deleted ccpA in the biofilm-forming strains SA113 and DSM
20231, yielding strains KS66 and KS157, respectively, and an-
alyzed the capacity of the mutants to form a biofilm. The
growth rates of the wild type and ccpA mutants were similar.
For demonstration of biofilm formation of strain DSM 20231,
the plates had to be precoated with 20% human plasma. The
deletion of ccpA significantly reduced the biofilm formation
capacity of the mutants under the respective static conditions
(Fig. 3A [only SA113 shown]), and complementation of the
ccpA mutants in trans, using pMST1, which contains the wild-
FIG. 1. (A) Quantification (A530) of biofilm formation of strain SA113 in different media in response to glucose. Results represent the averages
of at least three independent experiments. Error bars indicate the standard deviation of the mean A530. * and **, P 
 0.05 and P 
 0.01,
respectively, for unsupplemented versus supplemented cultures. The media contained the following concentrations of glucose and NaCl before
glucose addition: TSB, 0.25% glucose and 0.5% NaCl; BHI, 0.2% glucose and 0.5% NaCl; and LB, 0% glucose and 1% NaCl. (B) Biofilm stability
assays of SA113. Preformed biofilms were treated for 2 h with either sodium metaperiodate (10 mM) or proteinase K (100 g/ml). For the DNase
I stability assay, SA113 cells were grown for 18 h in the presence or absence of 140 U/ml DNase I.
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type ccpA allele, restored the biofilm formation capacities of
both mutants to wild-type levels (Fig. 3A [only SA113 shown]).
Transformation of the mutants with the empty control vector
had no effect (data not shown), signaling that the decrease in
biofilm formation observed in the ccpA mutants was due to
the deletion of ccpA. Biofilm formation for SA113 was further
analyzed by quantifying biofilm formation under static condi-
tions and by observing biofilm formation under flow cell con-
ditions (Fig. 3B and D). Both experiments confirmed the re-
duced capacity of the mutant to form biofilm. Inactivation of
ccpA had no apparent effect on the primary attachment of the
mutant to polystyrene surfaces. Both the wild type and mutant
showed approximately 10% primary adherence (data not
shown). Interestingly, the lack of ccpA in SA113 did suppress
the clumping phenotype in the presence of glucose observed
for the parental strain grown in glass tubes (Fig. 2). The ccpA
mutant also lost the ability of its parent to form black and
crusty-appearing colonies on CRA plates (Fig. 3C) and formed
smaller colonies on CRA. The reason for the latter phenom-
enon might be the slightly higher susceptibility of the mutant
(MIC of 1 g/liter versus 2 g/liter for Congo red), which was in
the range of the Congo red concentration in the agar (0.8
g/liter). The crustiness and black color on CRA have been
associated with PIA production (29) and might therefore in-
dicate that the ccpA mutant of strain SA113 produced less
PIA than the wild type. trans-Complementation of KS66 with
pMST1 restored both the colony morphology on CRA plates
and the clumping phenotype of SA113 cultures grown in glass
tubes, indicating that CcpA was involved in the development of
both phenotypes.
Effect of CcpA on ica expression and PIA production. To
support our proposed effect of CcpA on PIA production, we
quantified the icaA transcription and determined the PIA pro-
duction of SA113 and its ccpA mutant KS66 after 2 h (early
exponential growth phase) and 8 h (stationary phase) of
growth. Monitoring the icaA transcription after 2 h of growth
in TSB supplemented with 1% glucose revealed a clear differ-
ence between SA113 and KS66, with SA113 producing 0.113
0.006 copy of icaA per copy of gyrB, while deletion of ccpA
resulted in a sevenfold reduction in icaA transcription (0.015
0.004 copy of icaA per copy of gyrB for KS66), as compared to
the wild type (P 
 0.01). trans-Complementation of KS66 with
pMST1 strongly increased icaA transcription (0.47  0.144
copy of icaA per copy of gyrB), while transformation of KS66
with the empty control plasmid pAW17 did not alter the icaA
expression of the mutant (0.018  0.002 copy of icaA per copy
of gyrB) (Fig. 4 A). Surprisingly, after 8 h of growth, icaA
transcript levels were found to be strongly reduced and no
longer differed significantly between SA113 and KS66 (0.001
0.0004 copy of icaA per copy of gyrB for SA113 and 0.004 
0.004 copy of icaA per copy of gyrB for KS66; P  0.05).
Analysis of the PIA production in SA113 and its ccpA mutant
KS66 identified significant amounts of PIA only in SA113 but
not in KS66 (Fig. 4B). In line with our transcriptional data,
PIA was only detectable during the early exponential growth
phase (2 h), but not after 8 h of growth (data not shown).
trans-Complementation of KS66 with pMST1 restored PIA
production, while transformation of KS66 with pAW17 was
found to have no effect, signaling that CcpA is indeed influ-
encing ica transcription and PIA production in SA113.
Effect of CcpA on TCA cycle genes. Based on the observa-
tions of Vuong and coworkers (56a), who found that decreased
tricarboxylic acid (TCA) activity was associated with increased
PIA production in S. epidermidis, and on the findings of Kim et
al. (28), showing that transcription of the genes for the TCA
FIG. 3. (A) Effect of the ccpA deletion on biofilm formation ca-
pacity of S. aureus strain SA113 in TSB supplemented with 1% glucose.
wt, wild type. (B) Quantification (A530) of biofilm formation of SA113.
Results represent the averages of at least three independent experi-
ments. Error bars indicate the standard deviation of the mean. **, P

0.01 for wild type and KS66 trans-complemented with plasmid pMST1
(compl.) versus ccpA. (C) Growth morphologies of strain SA113 on
CRA plates. (D) Biofilm formation of strain SA113 under flow con-
ditions.
FIG. 2. Growth phenotype of SA113, KS66 (ccpA), KS66 trans-
complemented with plasmid pMST1 (compl.), and SA113 ica (ica)
grown for 18 h at 37°C in glass tubes in TSB ( Glc) or TSB supple-
mented with 1% glucose ( Glc).
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cycle enzymes CitB (aconitase) and CitZ (citrate synthase) are
influenced by CcpA in Bacillus subtilis, we monitored the effect
of CcpA on the transcription of citB and citZ in S. aureus under
biofilm inducing conditions. Similar to the findings of Vuong et
al. (56a) and Kim et al. (28), we found a strong increase in citB
and citZ transcription in KS66 during the early exponential
growth phase (Fig. 5), and trans-complementation of the
ccpA mutant with pMST1 reduced citB and citZ transcription
to levels seen in the wild type. We found a putative cre (catab-
olite-responsive element) site 27 bp upstream of the citZ open
reading frame (TgTGAAAGCcATTTCATA; capital letters
indicate nucleotides that correspond to the cre site consensus
of B. subtilis [38]), suggesting that CcpA affects the transcrip-
tion of citZ directly. The effect of CcpA on citB expression, on
the other hand, appears to be indirect because such an element
is missing in front of, or within, citB, similar to the situation
found in B. subtilis (28).
Effect of CcpA on the transcription of selected factors known
to be involved in the regulation of biofilm formation. A series
of genetic loci have been identified to influence the primary
attachment and/or the cellular accumulation process in S. au-
reus in addition to the ica operon (reviewed by O’Gara [39])
and Tu Quoc et al. [55]). Our special interest focused on the
impact of CcpA on the transcription of (i) rbf, due to its
demonstrated influence on biofilm formation in response to
glucose and salt (32); (ii) sarA, since the inactivation of sarA
was shown to abolish biofilm formation in SA113 (1); (iii) atl
and cidA, since they were shown to contribute to DNA release
and biofilm development (4, 26, 44); (iv) mgrA, an important
regulator of autolysis, which has recently been shown to be
involved in biofilm formation (55); and (v) arlRS, another
regulator of autolysis and cell division (21), since our compu-
tational analysis identified a putative cre (AATtTAAACGTA
AACAAA; capital letters indicate nucleotides that correspond
to the cre consensus of B. subtilis [38]) 95 bp downstream of the
arlRS transcriptional start site (21a). We therefore analyzed
the impact of CcpA on the transcription of arlRS, atl, mgrA, rbf,
cidABC, and the sarA locus by monitoring the expression of
these genes during the early exponential growth phase by
Northern blot analysis. These assays revealed no apparent dif-
ferences in arlRS, mgrA, rbf, or sarA transcription between the
wild-type strain and its corresponding ccpA mutant, suggest-
ing that CcpA is not affecting the regulation of these genes
(data not shown). The investigation of the effect of CcpA on atl
transcriptional levels suggested a tendency toward higher atl
expression in the wild type than in the mutant, though total
amounts of transcripts varied widely between separate exper-
iments (data not shown).
However, we found a clear effect of CcpA on cidABC tran-
scription, with SA113 producing significant amounts of cidABC,
while no transcript was observed in KS66 (Fig. 5), and trans-
complementation of the ccpA mutant with pMST1 led to the
production of cidABC transcripts again. The acetic acid con-
centration at the time point of sampling for Northern blot
analysis was 2 mM in the culture supernatant of both the wild
type and mutant. Because the acetic acid concentration was
lower than the concentration required for cidA induction (30
mM) according to reference 45, and the concentrations were
identical in the wild type and mutant, we suggest that there
may exist additional factors which can induce cidA transcrip-
tion. As mutation of cidA has been associated with reduced
autolysis (41), we analyzed the effect of the ccpA mutation on
Triton X-induced autolysis. The wild type showed slightly
faster autolysis, with 88%  9.0% of the cells lysed after 2 h,
while the mutant showed only 66%  3.7% lysis at this time
point. When trans-complementing the mutant with pMST1,
lysis was partially restored to 72%  6.3% after 2 h.
Conclusion. The rapid adaptation to environmental and nu-
tritional conditions is central to the success of S. aureus as
pathogen. The utilization of glucose as the preferred carbon
source is controlled in S. aureus by CcpA, the mediator of
carbon catabolite repression, which was shown earlier to pro-
mote the expression of selected virulence factors, increase the
expression of oxacillin resistance, and repress capsule synthesis
(50). The role of CcpA as a mediator of biofilm formation in
FIG. 5. Northern blot analysis of citB, citZ, and cidABC transcrip-
tion after 2 h of growth in TSB supplemented with 1% glucose. A 16S
rRNA gene probe was used for hybridization as a loading control. wt,
wild-type strain SA113; ccpA, strain KS66; compl., strain KS66 com-
plemented with pMST1; control, strain KS66 containing pAW17.
FIG. 4. (A) icaA transcription after 2 h of growth in TSB supple-
mented with 1% glucose. (B) Slot blot analysis of the PIA production
after 2 h of growth in TSB supplemented with 1% glucose. PIA extracts
were diluted as indicated. wt, wild-type strain SA113; ccpA, strain
KS66; compl., strain KS66 complemented with pMST1; control, strain
KS66 containing pAW17.
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the presence of glucose adds a further important function to
CcpA, contributing to staphylococcal virulence and persis-
tence. The positive impact of CcpA on biofilm formation in S.
aureus is partly in contrast to observations made in B. subtilis
(7, 53), where CcpA, depending on the growth medium, was
found to repress biofilm formation. However, biofilm forma-
tion in S. aureus differs widely from biofilm formation in B.
subtilis (8), which in the latter bacterium is closely related to
sporulation. The S. aureus biofilm was shown here to have a
complex composition, including PIA, proteinaceous factors,
and eDNA. CcpA had an impact on at least two of these
components: through upregulation of the ica operon, which is
involved in PIA synthesis; and through upregulation of cidA,
coding for the holin CidA, postulated to be involved in the
release of eDNA. Regulation of these genes, which are not
accompanied by a cre site, may have occurred indirectly, as a
consequence of the downregulation of the TCA cycle through
repression of citB and citZ, with citZ being preceded by a
typical cre consensus sequence recognized by CcpA. These
findings confirm the reported role of downregulation of the
TCA cycle in biofilm formation (28). The apparent correlation
between oxacillin resistance and the capacity to form a biofilm,
as observed in some methicillin-resistant S. epidermidis strains
(10), exists also in S. aureus and may be linked over CcpA.
Inactivation of CcpA in S. aureus, incapacitating biofilm
formation, reducing the expression of secreted virulence fac-
tors and lowering the expression of oxacillin resistance, makes
it an important player in overall staphylococcal virulence and
antibiotic resistance. These findings underline the important
linkage of metabolism to the envelope composition, virulence,
and resistance in S. aureus.
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